Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care

被引:90
作者
Harbarth, S
Ferrière, K
Hugonnet, S
Ricou, B
Suter, P
Pittet, D [1 ]
机构
[1] Univ Hosp Geneva, Infect Control Program, CH-1211 Geneva 14, Switzerland
[2] Univ Hosp Geneva, Dept Internal Med, Geneva, Switzerland
[3] Univ Hosp Geneva, Dept Anesthesiol Pharmacol & Surg Intens Care, Geneva, Switzerland
关键词
D O I
10.1001/archsurg.137.12.1353
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hypothesis: A set of clinical variables available at the bedside can be used to predict outcome in critically ill patients with bloodstream infection (BSI). Design: A 3-year retrospective cohort study. Setting: A surgical intensive care unit in Switzerland. Patients: All patients with BSI were potentially eligible. Main Outcome Measures: Clinical variables, organ dysfunctions, and outcome. Results: Among 4530 admissions to the surgical intensive care unit, 224 clinically significant episodes of BSI were recorded (incidence, 4.9%), with a 28-day fatality of 36%. A total of 110 patients had primary bacteremia, of which 39 (35%) were catheter related. Although gram-positive organisms were the most frequently isolated pathogens (58% [159/275]), they were associated with lower case-fatality (30%) than BSI due to gram-negative bacteria (44%). Organ dysfunctions associated with the highest risk of death were neurologic dysfunction (hazard ratio [HR], 6.9; 95% confidence interval [CI], 3.3-14.5), hepatic dysfunction (HR, 3.9; 95% CI, 2.1-7.4), and disseminated intravascular coagulation (HR, 3.0; 95% CI, 1.5-6.1). By multivariate analysis, 2 independent predictors of mortality were the APACHE II (Acute Physiology and Chronic Health Evaluation II) score at onset of BSI (HR per 1-point increase, 1.08; 95% CI, 1.04-1.12) and the number of evolving organ dysfunctions (HR, 1.4; 95% CI, 1.2-1.7). Appropriate antimicrobial therapy was associated with improved outcome (HR, 0.4; 95% CI, 0.2-0.6). Conclusions: Bloodstream infection in critically ill patients is a common and frequently fatal condition. Its outcome can be predicted by the severity of illness at onset of BSI and the number of organ dysfunctions evolving thereafter. Appropriate antimicrobial therapy is an important determinant for survival.
引用
收藏
页码:1353 / 1359
页数:7
相关论文
共 42 条
[1]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[2]   The American-European Consensus Conference on ARDS, Part 2 - Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling [J].
Artigas, A ;
Bernard, GR ;
Carlet, J ;
Dreyfuss, D ;
Gattinoni, L ;
Hudson, L ;
Lamy, M ;
Marini, JJ ;
Matthay, MA ;
Pinsky, MR ;
Spragg, R ;
Suter, PM ;
Blanch, L ;
Burchardi, H ;
Hedenstierna, C ;
Lemaire, F ;
Roussos, C ;
Mancebo, J ;
Morris, A ;
Pesenti, A ;
Rossi, A ;
Van Asbeck, BS ;
Brigham, KL ;
Dhainaut, JF ;
Fowler, AA ;
Hyers, TM ;
Morel, D ;
Rodriguez-Roisin, R ;
Schaller, MD ;
Hemmer, M ;
Torres, A ;
Villar, J ;
Vincent, JL ;
Leeper, K ;
Meyrick, B ;
Oppenheimer, L ;
Reid, L ;
Murray, JF ;
Bihari, D ;
Bosken, C ;
Goris, J ;
Johanson, WJ ;
Lanken, PN ;
Le Gall, JR ;
Morris, AH ;
Rinaldo, J ;
Pattishal, EN .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (04) :1332-1347
[3]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[4]   Antibiotics in sepsis [J].
Bochud, PY ;
Glauser, MP ;
Calandra, T .
INTENSIVE CARE MEDICINE, 2001, 27 (Suppl 1) :S33-S48
[5]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[6]   The epidemiology of the systemic inflammatory response [J].
Brun-Buisson, C .
INTENSIVE CARE MEDICINE, 2000, 26 (Suppl 1) :S64-S74
[7]   INCIDENCE, RISK-FACTORS, AND OUTCOME OF SEVERE SEPSIS AND SEPTIC SHOCK IN ADULTS - A MULTICENTER PROSPECTIVE-STUDY IN INTENSIVE-CARE UNITS [J].
BRUNBUISSON, C ;
DOYON, F ;
CARLET, J ;
DELLAMONICA, P ;
GOUIN, F ;
LEPOUTRE, A ;
MERCIER, JC ;
OFFENSTADT, G ;
REGNIER, B .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (12) :968-974
[8]  
BRYAN CS, 1983, REV INFECT DIS, V5, P629
[9]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[10]   Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care [J].
Eggimann, P ;
Harbarth, S ;
Constantin, MN ;
Touveneau, S ;
Chevrolet, JC ;
Pittet, D .
LANCET, 2000, 355 (9218) :1864-1868